Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 10, Pages 1418
Publisher
MDPI AG
Online
2019-09-23
DOI
10.3390/cancers11101418
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Estrogen receptors localization and signaling pathways in DU-145 human prostate cancer cells
- (2019) Deborah S. de Souza et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Estrogens Modulate Somatostatin Receptors Expression and Synergize With the Somatostatin Analog Pasireotide in Prostate Cells
- (2019) Valentina Rossi et al. Frontiers in Pharmacology
- Estrogen receptor α-NOTCH1 axis enhances basal stem-like cells and epithelial-mesenchymal transition phenotypes in prostate cancer
- (2019) Yongmei Shen et al. Cell Communication and Signaling
- Update on ERbeta
- (2019) Jan-Ake Gustafsson et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Estrogen-related receptor alpha induces epithelial-mesenchymal transition through cancer-stromal interactions in endometrial cancer
- (2019) Kaori Yoriki et al. Scientific Reports
- Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another Standard
- (2018) Nicolas Mottet et al. EUROPEAN UROLOGY
- Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology
- (2018) Philipp Nuhn et al. EUROPEAN UROLOGY
- Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
- (2018) Tetsuya Fujimura et al. Cancers
- Estrogens and Their Receptors in Prostate Cancer: Therapeutic Implications
- (2018) Erika Di Zazzo et al. Frontiers in Oncology
- Advancing therapies in metastatic castration-resistant prostate cancer
- (2018) Giulia Baciarello et al. EXPERT OPINION ON PHARMACOTHERAPY
- Consensus on molecular imaging and theranostics in prostate cancer
- (2018) Stefano Fanti et al. LANCET ONCOLOGY
- Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificity
- (2017) Adam W. Nelson et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression
- (2017) Bilal Bin Hafeez et al. MOLECULAR CANCER THERAPEUTICS
- The EMT spectrum and therapeutic opportunities
- (2017) Dominic C. Voon et al. Molecular Oncology
- PET/CT with 18 F–choline: Physiological whole bio-distribution in male and female subjects and diagnostic pitfalls on 1000 prostate cancer patients
- (2017) Ferdinando Calabria et al. NUCLEAR MEDICINE AND BIOLOGY
- DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells
- (2017) C Pistore et al. ONCOGENE
- Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression
- (2017) Helmut Bonkhoff PROSTATE
- Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells
- (2017) Xiaoyu Shi et al. PROSTATE
- Estrogen Receptor β as a Pharmaceutical Target
- (2017) Margaret Warner et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Insufficient antibody validation challenges oestrogen receptor beta research
- (2017) Sandra Andersson et al. Nature Communications
- Epithelial-mesenchymal transition in prostate cancer: an overview
- (2017) Micaela Montanari et al. Oncotarget
- Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer
- (2017) Dorota Jędroszka et al. PLoS One
- The emerging roles of orphan nuclear receptors in prostate cancer
- (2016) Dinglan Wu et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers
- (2016) Vincenzo Cuccurullo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- AR aberrations and resistance to abiraterone or enzalutamide
- (2016) Gerhardt Attard et al. Nature Reviews Urology
- Expression and regulation of the estrogen receptors in PC-3 human prostate cancer cells
- (2016) R. Pisolato et al. STEROIDS
- Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
- (2015) Tetsuya Fujimura et al. BMC CANCER
- Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells
- (2015) Dougba Noel Dago et al. BMC GENOMICS
- Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
- (2015) M. Ruscetti et al. CANCER RESEARCH
- Regulation of tumor cell plasticity by the androgen receptor in prostate cancer
- (2015) J. L. Bishop et al. ENDOCRINE-RELATED CANCER
- Estrogen Receptor β2 Induces Hypoxia Signature of Gene Expression by Stabilizing HIF-1α in Prostate Cancer
- (2015) Prasenjit Dey et al. PLoS One
- Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells
- (2015) Muyi Yang et al. PROSTATE
- Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancer
- (2015) Sweta Mishra et al. Oncotarget
- Prostate cancer stem cells: the role of androgen and estrogen receptors
- (2015) Erika Di Zazzo et al. Oncotarget
- Estrogen receptor beta in prostate cancer: friend or foe?
- (2014) Adam W Nelson et al. ENDOCRINE-RELATED CANCER
- Effects of estrogen-related receptor alpha (ERRα) on proliferation and metastasis of human lung cancer A549 cells
- (2014) Jian-wei Huang et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Epithelial-to-Mesenchymal Transition Mediates Docetaxel Resistance and High Risk of Relapse in Prostate Cancer
- (2014) M. Marin-Aguilera et al. MOLECULAR CANCER THERAPEUTICS
- Unknown
- (2014) Paraskevi Christoforou et al. MOLECULAR MEDICINE
- NUMB inhibition of NOTCH signalling as a therapeutic target in prostate cancer
- (2014) Angela N. Flores et al. Nature Reviews Urology
- Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia
- (2014) Rui Shao et al. PROSTATE
- The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
- (2014) Dimple Chakravarty et al. Nature Communications
- Estrogen receptor β expression and androgen receptor phosphorylation correlate with a poor clinical outcome in hormone-naïve prostate cancer and are elevated in castration-resistant disease
- (2013) Tobias Zellweger et al. ENDOCRINE-RELATED CANCER
- Integrative genomics of gene and metabolic regulation by estrogen receptors and , and their coregulators
- (2013) Z. Madak-Erdogan et al. Molecular Systems Biology
- Modulators of estrogen receptor inhibit proliferation and migration of prostate cancer cells
- (2013) Margherita Piccolella et al. PHARMACOLOGICAL RESEARCH
- Estrogen receptor sustains epithelial differentiation by regulating prolyl hydroxylase 2 transcription
- (2013) P. Mak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
- (2013) A. Aytes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SOX4 is associated with poor prognosis in prostate cancer and promotes epithelial–mesenchymal transition in vitro
- (2013) L Wang et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment
- (2013) Melanie J. Grubisha et al. STEROIDS
- Tamoxifen for the management of breast events induced by non-steroidal antiandrogens in patients with prostate cancer: a systematic review
- (2012) Frank Kunath et al. BMC Medicine
- Pten Loss and RAS/MAPK Activation Cooperate to Promote EMT and Metastasis Initiated from Prostate Cancer Stem/Progenitor Cells
- (2012) D. J. Mulholland et al. CANCER RESEARCH
- Aggressive Prostate Cancer Is Prevented in ERαKO Mice and Stimulated in ERβKO TRAMP Mice
- (2012) Anna Ślusarz et al. ENDOCRINOLOGY
- Toremifene to Reduce Fracture Risk in Men Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2012) Matthew R. Smith et al. JOURNAL OF UROLOGY
- Estrogen Receptors β1 and β2 Have Opposing Roles in Regulating Proliferation and Bone Metastasis Genes in the Prostate Cancer Cell Line PC3
- (2012) Prasenjit Dey et al. MOLECULAR ENDOCRINOLOGY
- Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
- (2011) Y. Sun et al. CANCER RESEARCH
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- ERβ Impedes Prostate Cancer EMT by Destabilizing HIF-1α and Inhibiting VEGF-Mediated Snail Nuclear Localization: Implications for Gleason Grading
- (2010) Paul Mak et al. CANCER CELL
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- Estrogen receptor β2 and β5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion
- (2010) Yuet-Kin Leung et al. ENDOCRINE-RELATED CANCER
- Estrogen receptor β and the progression of prostate cancer: role of 5α-androstane-3β,17β-diol
- (2010) Donatella Dondi et al. ENDOCRINE-RELATED CANCER
- Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
- (2010) Hiroshi Tanaka et al. NATURE MEDICINE
- Role of Cyclic AMP Response Element-Binding Protein in Insulin-like Growth Factor-I Receptor Up-regulation by Sex Steroids in Prostate Cancer Cells
- (2009) M. Genua et al. CANCER RESEARCH
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2
- (2009) Valentina Rossi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Endothelial NOS, estrogen receptor β, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer
- (2009) Simona Nanni et al. JOURNAL OF CLINICAL INVESTIGATION
- EMT: When epithelial cells decide to become mesenchymal-like cells
- (2009) Raghu Kalluri JOURNAL OF CLINICAL INVESTIGATION
- A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia
- (2009) Paloma Alonso-Magdalena et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- The role of estrogens and estrogen receptors in normal prostate growth and disease
- (2007) Gail S. Prins et al. STEROIDS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now